Literature DB >> 2883236

Lack of dendritic Thy-1+ epidermal cells in mice with severe combined immunodeficiency disease.

J L Nixon-Fulton, P L Witte, R E Tigelaar, P R Bergstresser, V Kumar.   

Abstract

C.B-17 scid (severe combined immunodeficiency disease) mice were used to evaluate the relationship of dendritic Thy-1+ epidermal cells (EC) to T lymphocytes (deficient in scid) and to NK cells (replete in scid). Epidermis from scid mice was deficient in dendritic Thy-1+ cells as determined by immunofluorescent staining of epidermal whole mounts. Similarly, epidermal cell suspensions from scid mice failed to proliferate in response to Con A, as compared with epidermal cell suspensions from C.B-17 control mice. Transplantation of normal bone marrow into scid mice reconstituted morphologically identifiable dendritic Thy-1+ EC in whole mounts, as well as Con A responsiveness of EC suspensions, thus indicating that the deficiency in dendritic Thy-1+ EC in scid mice is at the precursor level. These studies demonstrate that Thy-1+ EC are more closely related to T lymphocytes than to NK cells.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2883236

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  4 in total

Review 1.  Epidermal T lymphocytes--ontogeny, features and function.

Authors:  E Payer; A Elbe; G Stingl
Journal:  Springer Semin Immunopathol       Date:  1992

2.  T cell receptor expression is not required for the localization and differentiation of intraepithelial lymphocytes.

Authors:  K Croitoru; R H Stead; J Bienenstock; L D Shultz; P B Ernst
Journal:  Immunol Res       Date:  1991       Impact factor: 2.829

3.  Effect of genetically determined immunodeficiency on epidermal dendritic cell populations in C57BL/6J mice.

Authors:  E Sprecher; Y Becker; G Kraal; E Hall; L D Shultz
Journal:  Arch Dermatol Res       Date:  1990       Impact factor: 3.017

4.  The route of antigen entry determines the requirement for L-selectin during immune responses.

Authors:  M D Catalina; M C Carroll; H Arizpe; A Takashima; P Estess; M H Siegelman
Journal:  J Exp Med       Date:  1996-12-01       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.